Protecting innovation is essential in life sciences, where intellectual property often represents a company’s core enterprise value. Our attorneys counsel clients on the full life cycle of intellectual property development, protection, commercialization, and enforcement, including invention harvesting, patent prosecution, patent portfolio strategy, freedom-to-operate analyses, technology landscape assessments, portfolio management, technology licensing, intellectual property transactions, trade secrets, trademarks and branding, research and development collaborations, due diligence, and intellectual property litigation involving pharmaceuticals, diagnostics, medical devices, digital health technologies, and biotechnology innovations. We help clients align intellectual property strategy with financing, regulatory, and commercialization objectives; structure and negotiate licensing and collaboration arrangements; protect proprietary know-how and data assets; and develop global intellectual property portfolios designed to support growth, encourage investment, create competitive barriers to entry, and maximize value.